A detailed history of Hsbc Holdings PLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Hsbc Holdings PLC holds 14,286 shares of WVE stock, worth $192,575. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,286
Previous 21,444 33.38%
Holding current value
$192,575
Previous $107,000 9.35%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.12 - $9.01 $36,648 - $64,493
-7,158 Reduced 33.38%
14,286 $117,000
Q2 2024

Aug 12, 2024

BUY
$4.38 - $6.48 $93,924 - $138,957
21,444 New
21,444 $107,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.17B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.